Article Text

Download PDFPDF
Case report
Hemangiopericytoma of meningo-fronto-naso-orbito-maxillary complex
  1. Bhavuk Vanza1,
  2. Anshul Rai2,
  3. Neha Khare3 and
  4. HS Verma4
  1. 1Oral and Maxillofacial Surgery, Government Dental College, Indore, India
  2. 2Dentistry, All India Institute of Medical Science, Bhopal, India
  3. 3Periodontology, RKDF Dental College and Research Centre, Bhopal, India
  4. 4Department of Orthopaedics, NSCB Medical College, Jabalpur, India
  1. Correspondence to Dr Anshul Rai; anshulrai007{at}


Hemangiopericytoma (HPC) is a rare vascular tumour and difficult to diagnose clinically. Incidence is reported in fourth to fifth decade of life.With female predominance, 3%–5% cases affect the oral cavity, sinus lining and meninges. The patient presented with 8×6 cm swelling on her face, evaluation reported it to be HPC. Bilateral maxillary artery embolisation, wide local excision of the lesion, preserving the left eye and its function, was done. No recurrence is reported at 1-year follow-up. Response of such lesions to radiotherapy is questionable; with no lymphadenopathy and adequate encapsulation, embolisation of feeder vessel followed by a wide local excision of the lesion seems to be a fairly good option of treatment.

  • dentistry and oral medicine
  • oral and maxillofacial surgery

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Twitter @Dr Anshul Rai

  • Contributors BV and NK operated the case. AR and HSV helped in collecting the literature. AR guided in surgery and helped in preoperative planning and successful surgical outcome. AR kept the patient under follow-up and managed the patient postoperatively. All four authors are the guarantor of the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.